Treatment results of FOLFOX chemotherapy before surgery for lymph node metastasis of advanced colorectal cancer with synchronous liver metastasis: The status of LN metastasis and vessel invasions at the primary site in patients who responded to FOLFOX

International Journal of Clinical Oncology

Volumn 15, Issue 1, 2010, Pages 70-76

  Sawayama, Hiroshi ^a   Hayashi, Naoko ^a   Honda, Shinobu ^a   Baba, Yoshifumi ^a   Toyama, Eiichirou ^a   Watanabe, Masayuki ^a   Takamori, Hiroshi ^a   Beppu, Toru ^a   Baba, Hideo ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

Author keywords

Colorectal cancer; FOLFOX; Lymph node metastasis; Perioperative chemotherapy; Primary lesion

Indexed keywords

FLUOROURACIL; FOLINIC ACID; OXALIPLATIN;

ADULT; ADVANCED CANCER; AGED; ANEMIA; ANOREXIA; ARTICLE; BILE LEAKAGE; CANCER COMBINATION CHEMOTHERAPY; CANCER INVASION; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL ASSESSMENT; COLON RESECTION; COLORECTAL CANCER; DIARRHEA; DRUG EFFICACY; DRUG HYPERSENSITIVITY; FEMALE; HEMATOLOGIC DISEASE; HUMAN; LEUKOPENIA; LIVER METASTASIS; LIVER RESECTION; LYMPH NODE METASTASIS; MALE; MULTIPLE CYCLE TREATMENT; NEUTROPENIA; OVERALL SURVIVAL; PERIPHERAL NEUROPATHY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; SURVIVAL RATE; THROMBOCYTOPENIA; TREATMENT DURATION; TREATMENT RESPONSE;

AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; COLORECTAL NEOPLASMS; COMBINED MODALITY THERAPY; FEMALE; FLUOROURACIL; HUMANS; LEUCOVORIN; LIVER NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; ORGANOPLATINUM COMPOUNDS; TREATMENT OUTCOME; VASCULAR NEOPLASMS;

EID: 77950917018     PISSN: 13419625     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10147-009-0013-5     Document Type: Article

References (19)

1. de Gramont A, Boni C, Navarro M, Tabernero J, Hickish T, Topham C, Bonetti A, Clingan P, Lorenzato C, André T (2007) Oxaliplatin/5FU/LV in adjuvant colon cancer: updated efficacy results of the MOSAIC trial, including survival, with a median follow-up of six years. J Clin Oncol 2007 ASCO Annu Meet Proc Pt I 25(18S):4007
2. T Andre C Boni L Mounedji-Boudiaf, et al. 2004 Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer N Engl J Med 350 2343 2351 10.1056/NEJMoa032709 1:CAS:528:DC%2BD2cXks1Gjt78%3D 15175436 (Pubitemid 38702845)
3. T Andre C Tournigand E Achille, et al. 2006 Adjuvant treatment of colon cancer MOSAIC study's main results Bull Cancer 93 Suppl 1 S5 S9 1:CAS:528:DC%2BD28XkvVSlsrk%3D 16483940
4. JP Kuebler HS Wieand MJ O'Connell, et al. 2007 Oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: results from NSABP C-07 J Clin Oncol 25 2198 2204 10.1200/JCO.2006.08.2974 1:CAS:528:DC%2BD2sXnsVShtL0%3D 17470851 (Pubitemid 46954643)
5. AC Reinacher-Schick WO Bechstein 2007 Colorectal liver metastases: neoadjuvant chemotherapy: aspects of medical and surgical oncology Internist (Berlin) 48 51 58 10.1007/s00108-006-1770-0 (Pubitemid 46181536)
6. B Nordlinger H Sorbye B Glimelius, et al. 2008 Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial Lancet 371 1007 1016 10.1016/S0140-6736(08)60455-9 1:CAS:528: DC%2BD1cXjs1Sltbg%3D 18358928 (Pubitemid 351392040)
7. SR Alberts WL Horvath WC Sternfeld, et al. 2005 Oxaliplatin, fluorouracil, and leucovorin for patients with unresectable liver-only metastases from colorectal cancer: a North Central Cancer Treatment Group Phase II Study J Clin Oncol 23 9243 9249 10.1200/JCO.2005.07.740 1:CAS:528: DC%2BD28Xnt1yntw%3D%3D 16230673 (Pubitemid 46260180)
8. M Lorenz E Staib-Sebler C Gog, et al. 2003 Prospective pilot study of neoadjuvant chemotherapy with 5-fluorouracil, folinic acid and oxaliplatin in resectable liver metastases of colorectal cancer. Analysis of 42 neoadjuvant chemotherapies Zentralbl Chir 128 87 94 10.1055/s-2003-37760 12632273 (Pubitemid 36342913)
9. FG Fernandez J Ritter JW Goodwin, et al. 2005 Effect of steatohepatitis associated with irinotecan or oxaliplatin pretreatment on resectability of hepatic colorectal metastases J Am Coll Surg 200 845 853 10.1016/j.jamcollsurg. 2005.01.024 15922194 (Pubitemid 40744790)
10. D Zorzi A Laurent TM Pawlik, et al. 2007 Chemotherapy-associated hepatotoxicity and surgery for colorectal liver metastases Br J Surg 94 274 286 10.1002/bjs.5719 1:CAS:528:DC%2BD2sXkt12nt7s%3D 17315288 (Pubitemid 46423843)
11. AJ Bilchik G Poston SA Curley, et al. 2005 Neoadjuvant chemotherapy for metastatic colon cancer: a cautionary note J Clin Oncol 23 9073 9078 10.1200/JCO.2005.03.2334 1:CAS:528:DC%2BD28Xnt1ygsQ%3D%3D 16361615 (Pubitemid 46260162)
12. M Minagawa J Yamamoto S Miwa, et al. 2006 Selection criteria for simultaneous resection in patients with synchronous liver metastasis Arch Surg 141 10 1006 1012 10.1001/archsurg.141.10.1006 17043279 (Pubitemid 44583259)
13. National Comprehensive Cancer Network (2007) NCCN clinical practice guidelines in oncology, colon cancer, rectal cancer. http://www.nccn.org
14. Nordlinger BSH, Debois M et al (2005) Feasibility and risks of pre-operative chemotherapy (CT) with FolFox 4 and surgery for resectable colorectal cancer liver metastases (LM): interim results of the EORTC Intergroup Randomized Phase III Study 40983. J Clin Oncol 23:253S
15. TE Le Voyer ER Sigurdson AL Hanlon, et al. 2003 Colon cancer survival is associated with increasing number of lymph nodes analyzed: a secondary survey of intergroup trial INT-0089 J Clin Oncol 21 2912 2919 10.1200/JCO.2003.05.062 1:STN:280:DC%2BD3szltlersA%3D%3D 12885809 (Pubitemid 46621841)
16. F Larminat VA Bohr 1994 Role of the human ERCC-1 gene in gene-specific repair of cisplatin-induced DNA damage Nucleic Acids Res 22 3005 3010 10.1093/nar/22.15.3005 1:CAS:528:DyaK2cXmt1ems7w%3D 8065913 (Pubitemid 24260628)
17. P Danoy E Sonoda M Lathrop, et al. 2007 A naturally occurring genetic variant of human XRCC2 (R188H) confers increased resistance to cisplatin-induced DNA damage Biochem Biophys Res Commun 352 763 768 10.1016/j.bbrc.2006.11.083 1:CAS:528:DC%2BD28Xhtleis7rO 17141189 (Pubitemid 44880321)
18. Q Li JJ Yu C Mu, et al. 2000 Association between the level of ERCC-1 expression and the repair of cisplatin-induced DNA damage in human ovarian cancer cells Anticancer Res 20 645 652 1:CAS:528:DC%2BD3cXjsVersLY%3D 10810335 (Pubitemid 30240614)
19. OH Temmink EK Hoebe K van der Born, et al. 2007 Mechanism of trifluorothymidine potentiation of oxaliplatin-induced cytotoxicity to colorectal cancer cells Br J Cancer 96 231 240 10.1038/sj.bjc.6603549 1:CAS:528:DC%2BD2sXotFeksw%3D%3D 17242697 (Pubitemid 46160627)